Ameriprise’s Hyliion Holdings HYLN Stock Holding History

Ameriprise’s Portfolio HYLN Stock Details HYLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-21,878	Closed	-$136K	–	3979
2021 Q4	$136K	Buy	+21,878	New	+$156K	﹤0.01%	3840

Other funds holding HYLN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameriprise's HYLN Position: Q1 2022 in Review

Ameriprise sold out of Hyliion Holdings (HYLN) in Q1 2022, closing a stake of 21,878 shares — an estimated $136K sold.

Ameriprise first reported a position in HYLN in Q4 2021 and held it in 1 quarter. The position peaked at $136K in Q4 2021. 131 funds tracked by Wall St. Rank hold HYLN as of Q1 2022.

Ameriprise reported no remaining Hyliion Holdings position as of Q1 2022 after selling out during the quarter.
Ameriprise sold 21,878 Hyliion Holdings shares in Q1 2022, an estimated $136K.
Ameriprise first reported a position in Hyliion Holdings in Q4 2021 and held it in 1 quarter.
Ameriprise's Hyliion Holdings position peaked at $136K in Q4 2021.
131 funds tracked by Wall St. Rank held Hyliion Holdings as of Q1 2022.

Based on Ameriprise's 13F filing for Q1 2022, filed 16 May 2022.